CD274 and cancer: Immunotherapy has revolutionised cancer treatment by modulating immune responses, primarily through checkpoint inhibitors targeting pathways like CTLA-4 and PD-1/PD-L1, which normally maintain self-tolerance by regulating T-cell activation [142].